NasdaqCM - Nasdaq Real Time Price USD

Instil Bio, Inc. (TIL)

13.23
+0.20
+(1.53%)
At close: May 9 at 4:00:01 PM EDT
13.40
+0.17
+(1.28%)
After hours: May 9 at 6:01:38 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
0
0
0
0
0
Operating Expense
56,048
56,048
87,157
203,291
155,560
Operating Income
-56,048
-56,048
-87,157
-203,291
-155,560
Net Non Operating Interest Income Expense
-2,005
-2,005
3,657
1,772
80
Other Income Expense
-16,082
-16,082
-72,587
-23,731
-1,275
Pretax Income
-74,135
-74,135
-156,087
-225,250
-156,755
Tax Provision
-408
--
0
-2,073
39
Net Income Common Stockholders
-74,135
-74,135
-156,087
-223,177
-156,794
Diluted NI Available to Com Stockholders
-74,135
-74,135
-156,087
-223,177
-156,794
Basic EPS
-11.39
--
-24.00
-34.40
-29.60
Diluted EPS
-11.39
--
-24.00
-34.40
-29.60
Basic Average Shares
6,510.14
--
6,503.91
6,475.63
5,299.66
Diluted Average Shares
6,510.14
--
6,503.91
6,475.63
5,299.66
Total Operating Income as Reported
-73,541
-73,541
-159,169
-226,458
-155,560
Total Expenses
56,048
56,048
87,157
203,291
155,560
Net Income from Continuing & Discontinued Operation
-74,135
-74,135
-156,087
-223,177
-156,794
Normalized Income
-56,642
-56,642
-84,075
-200,218.50
-156,794
Interest Income
6,987
6,987
8,866
3,655
80
Interest Expense
7,997
7,997
4,214
1,883
0
Net Interest Income
-2,005
-2,005
3,657
1,772
80
EBIT
-66,138
-66,138
-151,873
-223,367
-156,755
EBITDA
-62,528
-62,528
-147,117
-217,380
-154,003
Reconciled Depreciation
3,610
3,610
4,756
5,987
2,752
Net Income from Continuing Operation Net Minority Interest
-74,135
-74,135
-156,087
-223,177
-156,794
Total Unusual Items Excluding Goodwill
-17,493
-17,493
-72,012
-23,167
0
Total Unusual Items
-17,493
-17,493
-72,012
-23,167
0
Normalized EBITDA
-45,035
-45,035
-75,105
-194,213
-154,003
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
-208.50
0
12/31/2021 - 3/19/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

ANRO Alto Neuroscience, Inc.
2.2200
+1.37%
 
HLVX HilleVax, Inc.
1.9000
-0.52%
 
PMVP PMV Pharmaceuticals, Inc.
0.8827
-0.12%
 
SPRO Spero Therapeutics, Inc.
0.6200
+7.83%
 
ANTX AN2 Therapeutics, Inc.
1.2000
-1.64%
 
KZR Kezar Life Sciences, Inc.
4.2200
+2.43%
 
KROS Keros Therapeutics, Inc.
13.65
-2.64%
 
ASMB Assembly Biosciences, Inc.
12.24
+4.97%
 
GBIO Generation Bio Co.
0.3600
+0.06%
 
IPSC Century Therapeutics, Inc.
0.5370
+3.27%